Caris Life SciencesvsUnitedHealth

CAI and UNH stock compared: price, dividend, valuation and results, from SEC filings.

CAI

Caris Life Sciences, Inc.

$18.54

Value $5.2B

-4.92%
CAI's page

UNH

UnitedHealth Group Incorporated

$330.48

Value $300B

-5.55%
UNH's page

Caris Life Sciences (CAI) has a market value of $5.2B and UnitedHealth (UNH) $300B. Over the last year, with dividends, CAI moved -22.0% and UNH +8.2%. The P/E is 54.5 for CAI and 18.9 for UNH. Dividend yield: CAI none, UNH 2.74%.

At a glance

The main figures of both. A bar only shows which number is larger, not which is better.

  • Market value

    CAI$5.2B

    UNH$300B

    UNH is 57 times CAI

  • Revenue, 12 months

    CAI$1.0B

    UNH$450B

    UNH is 429 times CAI

  • Net income, 12 months

    CAI$96M

    UNH$15.9B

    UNH is 165 times CAI

  • Operating margin

    CAI13.4%

    UNH5.3%

    8.1 points apart

  • ROIC

    CAI11.5%

    UNH11.3%

    0.2 points apart

  • P/E

    CAI54.5

    UNH18.9

    CAI is 2.9 times UNH

  • Dividend yield

    CAI0.0%

    UNH2.7%

    2.7 points apart

A fainter bar means a negative number. The 5-year return includes dividends.

The price over time

Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.

CAI-22.0%

UNH+8.2%

75100125DecFebAprJunAugOct
Returns by period
PeriodCAIWith dividendsUNHWith dividends
1 year since November 18, 2025-22.0%Price -22.0%+8.2%Price +5.4%

Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.

Every figure

As on each company's page. A description, not a recommendation: no one figure says which is better.

CAICaris Life SciencesUNHUnitedHealth

Valuation

CAIUNH
Valuation
Price$18.54$330.48
Market value$5.2B$300B
Enterprise value (EV)–$346B
P/E54.518.9
P/E, 5-year median–25.0
P/B8.22.9
EV/EBIT–14.5
Free cash flow yield0.5%7.6%

Results and growth

CAIUNH
Results and growth
Revenue, 12 months$1.0B$450B
Net income, 12 months$96M$15.9B
Free cash flow, 12 months$29M$22.8B
Earnings per share, 12 months$0.34$17.52
Revenue growth, year on year97.0%11.8%
Revenue growth a year, past+62.9%over 2 years+11.7%over 5 years
EPS growth a year, past–-3.8%over 5 years

Margins and returns on capital

CAIUNH
Margins and returns on capital
Gross margin–88.3%
Operating margin13.4%5.3%
Net margin9.2%3.5%
ROIC11.5%11.3%
ROE16.7%15.5%

Balance sheet

CAIUNH
Balance sheet
Cash–$28.5B
Total debt–$74.3B
Net debt / EBITDA–1.6
Interest cover3.3×6.2×

Dividends and buybacks

CAIUNH
Dividends and buybacks
Dividend yield–2.7%
Dividend per share, 12 months–$9.06
Dividend growth a year, past–+12.6%over 5 years
Buyback yield0.0%1.8%
Shareholder yield–4.6%

Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.

Questions: CAI or UNH

Didn't find what you were looking for?

Ask us
Which is bigger, Caris Life Sciences or UnitedHealth?

By market value, UnitedHealth ($300B) is about 57.3 times Caris Life Sciences ($5.2B), at today's prices.

How did CAI and UNH stock do over the last 1 years?

Since November 18, 2025, CAI's price moved -22.0% and UNH's +5.4%. With dividends: CAI -22.0% (-22.0% a year), UNH +8.2% (+8.2% a year). Past returns do not predict future ones.

Which pays the higher dividend, CAI or UNH?

The dividend yield at today's price is none for Caris Life Sciences and 2.74% for UnitedHealth. Over the last twelve months they paid – and $9.06 per share.

What is the P/E of CAI and UNH?

At today's price, the P/E is 54.5 for CAI and 18.9 for UNH. It is the share price over the last twelve months' earnings per share.

Which has the higher profit margins, Caris Life Sciences or UnitedHealth?

Over the last twelve months, the net margin was 9.2% for Caris Life Sciences and 3.5% for UnitedHealth, and the operating margin 13.4% and 5.3%. Revenue was $1.0B and $450B.

Which is the better investment, Caris Life Sciences or UnitedHealth?

The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.

Other comparisons

With each of the two, and with the largest in its sector.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

Descriptive data from SEC filings and market prices.